CDKN3 and cervical cancer: Upregulation of CDKN3 is considered to be a key factor in promoting tumor cell proliferation and malignant transformation in ovarian cancer, cervical cancer, lung adenocarcinoma and leukemia, and is a potential molecular target for antitumor therapy (33–36).